Table I.
FBW7 is mutated in a high percentage of primary human T-ALL samples
Patient number |
Diagnostic/relapse sample |
FBXW7 sequence NM_033632.2 |
Predicted amino acid change |
---|---|---|---|
602-783 | Diagnosis | C1542T | R465C |
603-932 | Diagnosis | C1542T | R465C |
1 | Diagnosis | NA | NA |
Relapse | C1542T (homozygous) | R465C | |
4 | Diagnosis | WT | WT |
Relapse | C1542T | R465C | |
17 | Diagnosis | C1542T | R465C |
Relapse | C1542T | R465C | |
16 | Diagnosis | G1543A | R465H |
Relapse | G1543A | R465H | |
602-455 | Diagnosis | G1543A | R465H |
601-268 | Diagnosis | G1543A | R465H |
27 | Diagnosis | WT | WT |
Relapse | G1543A | R465H | |
4451 | Diagnosis | G1585A | R479Q |
602-839 | Diagnosis | G1585A | R479Q |
603-473 | Diagnosis | G1585A | R479Q |
29 | Diagnosis | C1662T | R505C |
Relapse | C1662T | R505C | |
22 | Diagnosis | WT | WT |
Relapse | C1662T | R505C | |
35 | Diagnosis | WT | WT |
Relapse | G1663T | R505L |